相关实验视频
Updated: Jun 27, 2025

07:04
Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology
Published on: May 2, 2025
298
在PD-1/PD-L1通路下治疗冠状动脉瘤的新进展
1Trauma Department of Orthopedics, The Second Hospital of Shandong University, Jinan, China.
Journal of cancer research and therapeutics
|April 30, 2024
概括
由于有限的治疗选择和对传统疗法的耐药性,冠状腺癌治疗仍然具有挑战性. 本综述探讨了编程细胞死亡蛋白-1 (PD-1) 和编程细胞死亡联体-1 (PD-L1) 阻断疗法的潜力,以改善冠状腺癌患者的治疗结果.
科学领域:
- 整形外科 整形外科 整形外科
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
背景情况:
- 软骨肉瘤是一种常见的骨肉瘤,尽管进行了积极的治疗,但结果不佳.
- 现有的手术,化疗和放射治疗等疗法显示出有限的疗效,耐药性很常见.
研究的目的:
- 审查当前的软骨肉瘤治疗方法.
- 检查抗编程细胞死亡蛋白-1 (PD-1) 和抗编程细胞死亡配体-1 (PD-L1) 阻塞疗法的进展.
主要方法:
- 对当前软骨肉瘤治疗方法的文献综述.
- 对癌症中PD-1/PD-L1阻断的研究分析.
- 检查免疫检查点在软骨肉瘤进展中的作用.
主要成果:
- 随着当前的软骨肉瘤治疗,患者结局的改善有限.
- 免疫检查点抑制剂,包括PD-1/PD-L1抑制剂,在各种癌症中显示出有前途.
- PD-1/PD-L1通路与瘤免疫逃避和进展有关.
结论:
- 对于冠状腺癌需要新的治疗策略.
- 抗PD-1/PD-L1疗法代表了对软骨肉瘤治疗的潜在新途径.
- 需要进一步研究PD-1/PD-L1阻断对冠状肉瘤的作用.
相关概念视频
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Tumor Immunotherapy
520
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
520
Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K

